BYFAVO® (remimazolam) for injection
Induction and maintenance of procedural sedation
Approved/CommercialActive
Key Facts
Indication
Induction and maintenance of procedural sedation
Phase
Approved/Commercial
Status
Active
Company
About Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company with a strategic focus on critical care and oncology, dedicated to discovering, developing, and marketing medicines that matter. The company has transitioned from a portfolio-based model to one with a diversified pipeline of internally and externally sourced candidates, including novel new chemical entities. Recent strategic moves include the divestiture of BARHEMSYS to sharpen its focus on its core pipeline and commercial assets like BYFAVO.
View full company profile